Spiramycin

DRUG4 trials

Sponsors

Assistance Publique Hopitaux De Paris, Rhone-Poulenc Rorer, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

CryptosporidiosisEA-COPD (with mechanical ventilationHIV InfectionsToxoplasmosisinvasive or non-invasiveor high-flow nasal oxygen therapy).

Phase 1

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

CompletedNCT00000980

Rhone-Poulenc RorerCryptosporidiosis, HIV Infections

Target: 25Updated: 2005-06-24

Phase 3

Use of MULTIplex PCR, procalcitonin and the appearance of sputum to reduce the duration of antibiotic therapy during severe COPD EXAcerbation: a trial controlled, randomized, open, in parallel groups, multicenter (MULTI-EXA)

RecruitingCTIS2024-511896-13-00

Assistance Publique Hopitaux De ParisEA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).

Start: 2022-12-09Target: 204Updated: 2025-01-28

Phase 4

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

RecruitingNCT00004317

National Institute of Allergy and Infectious Diseases (NIAID)Toxoplasmosis

Start: 2000-07-31End: 2030-12-31Target: 600Updated: 2009-05-14

Unknown Phase

Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients

CompletedNCT00002062

Rhone-Poulenc RorerCryptosporidiosis, HIV Infections

Updated: 2005-06-24

Related Papers

Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009).

2012-04-11116 citations